未登录

Y

Yasutomo Nakai

department of urology

H指数:26

被引数:3,758

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trends in real-world outcomes of patients with metastatic renal cell cancer in the recent treatment era: a single-institution analysis

近期治疗时代转移性肾细胞癌患者真实世界结局趋势：一项单机构分析

international journal of oncology

IF2.8

2025-07-140

PRE

The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2024-05-232

OAAI

Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients

CANCER GENE THERAPY

IF5

2017-05-1214

OAAI

PHASE I/II CLINICAL TRIAL TO ASSESS SAFETY AND EFFICACY OF INTRATUMORAL AND SUBCUTANEOUS INJECTION OF HVJ-E TO CASTRATION RESISTANT PROSTATE CANCER PATIENTS

JOURNAL OF UROLOGY

IF6.8

2016-04-010

OAAI

Evaluation of PSF1 as a prognostic biomarker for prostate cancer

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2014-11-1821

OAAI

Serum fucosylated haptoglobin is a novel prognostic biomarker for prostate cancer: Detailed analyses of its oligosaccharide structures

CANCER RESEARCH

IF16.6

2014-10-011

PRE

BONE MARROW DERIVED CELLS CONTRIBUTE TO REGENERATION OF INJURED PROSTATE EPITHELIUM AND STROMA

JOURNAL OF UROLOGY

IF6.8

2014-04-010

PREAI

PREOPERATIVE RISK STRATIFICATION FOR CANCER-SPECIFIC SURVIVAL OF PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA TREATED BY NEPHROURETERECTOMY

JOURNAL OF UROLOGY

IF6.8

2014-04-010

PREAI

ENDOTHELIAL EXPRESSION OF ENDOGLIN IN UPPER URINARY TRACT UROTHELIAL CARCINOMA IS ASSOCIATED WITH INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY

JOURNAL OF UROLOGY

IF6.8

2014-04-010

PREAI

Monotherapeutic high-dose-rate brachytherapy for prostate cancer: A dose reduction trial

RADIOTHERAPY AND ONCOLOGY

IF5.3

2014-01-0112

PREAI

Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-Myc

MOLECULAR CANCER RESEARCH

IF4.7

2013-09-1636

PREAI

TRAIL and Noxa are selectively up-regulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by non-replicating Sendai virus particles.

CANCER RESEARCH

IF16.6

2013-04-010

PRE

EMMPRIN PROMOTES ANGIOGENESIS, PROLIFERATION AND INVASION OF RENAL CELL CARCINOMA AND BE A PREDICTOR OF PATIENT OUTCOME

JOURNAL OF UROLOGY

IF6.8

2013-04-010

PREAI

EXPRESSION OF GANGLIOSIDES, GD1A AND SIALYL PARAGLOBOSIDE, IS REGULATED BY NF-κB-DEPENDENT TRANSCRIPTIONAL CONTROL OF α2,3-SIALYLTRANSFERASE I, II AND VI IN HUMAN CASTRATION-RESISTANT PROSTATE CANCER CELLS

JOURNAL OF UROLOGY

IF6.8

2012-04-010

PREAI

IMPACT OF HYPONATREMIA ON SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH MOLECULAR TARGETED THERAPY

JOURNAL OF UROLOGY

IF6.8

2012-04-010

PREAI

GENETIC POLYMORPHISMS OF CYP17A1 MAY PREDICT EARLY PROGRESSION AFTER PRIMARY ANDROGEN DEPRIVATION THERAPY IN JAPANESE MEN WITH PROSTATE CANCER

JOURNAL OF UROLOGY

IF6.8

2011-04-010

PREAI

ADJUVANT PLATINUM-BASED CHEMOTHERAPY IMPROVED THE PROGNOSIS OF PATIENTS WITH PT3N0/XM0 UPPER URINARY TRACT CARCINOMA

JOURNAL OF UROLOGY

IF6.8

2011-04-010

PREAI

Excision repair cross complementing group 1 (ERCC1) predicts the efficacy of chemoradiotherapy for invasive bladder cancer

CANCER RESEARCH

IF16.6

2011-04-010

PRE

Mechanism of efficient eradication of castration-resistant human prostate cancer cells by inactivated Sendai virus particle

CANCER RESEARCH

IF16.6

2011-04-010

PRE

Increased number of mast cells infiltrating in non-malignant biopsy is associated with detection of prostate cancer

CANCER RESEARCH

IF16.6

2011-04-010

PRE